Drug Name:
ATRAPRO ANTIPRURITIC HYDROGEL Rx
Generic Name and Formulations:
Sodium lithium magnesium fluorosilicate, dimethicone, sodium phosphate, sodium bicarbonate, sodium chloride, sodium sulfate, water, hypochlorus acid, sodium hypochlorite; topical gel.
Company:
Exeltis USA
Therapeutic Use:
Indications for ATRAPRO ANTIPRURITIC HYDROGEL:
To manage and relieve the pain, burning and itching associated with various dermatoses, including atopic and radiation dermatitis. May be used to relieve pain of first and second degree burns.
Adult:
Apply to affected area 3 times daily (or as needed). Allow to dry. Bandage as needed.
Children:
Not recommended.
Warnings/Precautions:
Avoid contact with eyes. Discontinue if sensitivity or chemical irritation occurs.
Pharmacological Class:
Antipruritic (nonsteroidal).
How Supplied:
Gel—4oz
Neurology Advisor Articles
- Ajovy Injection Approved for Migraine Prevention in Adults
- Few With Acute Migraine Take Triptans, Many Discontinue the Drug
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Noninvasive Ventilation Effective in Amyotrophic Lateral Sclerosis Treatment
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- Drug Prices Increase More Than Expected After Shortages
- Potentially Inappropriate Opioid Prescribing Tied to Overdose
- Loss of Function Variants in LRKK1 and LRKK2 Not Linked to Parkinson Disease
Sign Up for Free e-newsletters
Check out what's trending
CME Focus
Tardive Dyskinesia Clinical Commentary
CME
1.00 Credits
Breaking the Vaccination Barrier in Adults
CME|CE
1.25 Credits